Most cited article - PubMed ID 11553299
Effects of steroids on NMDA receptors and excitatory synaptic transmission in neonatal motoneurons in rat spinal cord slices
NMDA receptors are ligand-gated ion channels permeable to calcium and play a critical role in excitatory synaptic transmission, synaptic plasticity, and excitotoxicity. They are heteromeric complexes of NR1 combined with NR2A-D and/or NR3A-B subunits that are activated by glutamate and glycine and whose activity is modulated by allosteric modulators. In this study, patch-clamp recordings from human embryonic kidney 293 cells expressing NR1/NR2 receptors were used to study the molecular mechanism of the endogenous neurosteroid 20-oxo-5beta-pregnan-3alpha-yl sulfate (3alpha5betaS) action at NMDA receptors. 3alpha5betaS was a twofold more potent inhibitor of responses mediated by NR1/NR2C-D receptors than those mediated by NR1/NR2A-B receptors. The structure of the extracellular loop between the third and fourth transmembrane domains of the NR2 subunit was found to be critical for the neurosteroid inhibitory effect. The degree of 3alpha5betaS-induced inhibition of responses to glutamate was voltage independent, with recovery lasting several seconds. In contrast, application of 3alpha5betaS in the absence of agonist had no effect on the subsequent response to glutamate made in the absence of the neurosteroid. A kinetic model was developed to explain the use-dependent action of 3alpha5betaS at NMDA receptors. In accordance with the model, 3alpha5betaS was a less potent inhibitor of NMDA receptor-mediated EPSCs and responses induced by a short application of 1 mm glutamate than of those induced by a long application of glutamate. These results suggest that 3alpha5betaS is a use-dependent but voltage-independent inhibitor of NMDA receptors, with more potent action at tonically than at phasically activated receptors. This may be important in the treatment of excitotoxicity-induced neurodegeneration.
- MeSH
- Cell Line MeSH
- Hippocampus cytology physiology MeSH
- Rats MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Membrane Potentials drug effects physiology MeSH
- Patch-Clamp Techniques MeSH
- Models, Neurological MeSH
- Neocortex physiology MeSH
- Animals, Newborn MeSH
- Pregnanes pharmacology MeSH
- Receptors, N-Methyl-D-Aspartate antagonists & inhibitors MeSH
- In Vitro Techniques MeSH
- Transfection MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- 20-oxo-5beta-pregnan-3alpha-yl sulfate MeSH Browser
- Pregnanes MeSH
- Receptors, N-Methyl-D-Aspartate MeSH
NMDA receptors are highly expressed in the CNS and are involved in excitatory synaptic transmission and synaptic plasticity as well as excitotoxicity. They have several binding sites for allosteric modulators, including neurosteroids, endogenous compounds synthesized by the nervous tissue and expected to act locally. Whole-cell patch-clamp recording from human embryonic kidney 293 cells expressing NR1-1a/NR2B receptors revealed that neurosteroid pregnenolone sulfate (PS) (300 microm), when applied to resting NMDA receptors, potentiates the amplitude of subsequent responses to 1 mm glutamate fivefold and slows their deactivation twofold. The same concentration of PS, when applied during NMDA receptor activation by 1 mm glutamate, has only a small effect. The association and dissociation rate constants of PS binding and unbinding from resting NMDA receptors are estimated to be 3.3 +/- 2.0 mm(-1)sec(-1) and 0.12 +/- 0.02 sec(-1), respectively, corresponding to an apparent affinity K(d) of 37 microm. The results of experiments indicate that the molecular mechanism of PS potentiation of NMDA receptor responses is attributable to an increase in the peak channel open probability (P(o)). Responses to glutamate recorded in the continuous presence of PS exhibit marked time-dependent decline. Our results indicate that the decline is induced by a change of the NMDA receptor affinity for PS after receptor activation. These results suggest that the PS is a modulator of NMDA receptor P(o), the effectiveness of which is lowered by glutamate binding. This modulation may have important consequences for the neuronal excitability.
- MeSH
- Models, Biological MeSH
- Ion Channel Gating drug effects MeSH
- Hippocampus cytology MeSH
- Kinetics MeSH
- Rats MeSH
- Cells, Cultured MeSH
- Glutamic Acid pharmacology MeSH
- Humans MeSH
- Patch-Clamp Techniques MeSH
- Neurons drug effects metabolism MeSH
- Animals, Newborn MeSH
- Probability MeSH
- Pregnenolone pharmacology MeSH
- Receptors, N-Methyl-D-Aspartate agonists drug effects metabolism MeSH
- Recombinant Proteins agonists MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Glutamic Acid MeSH
- NR1 NMDA receptor MeSH Browser
- NR2B NMDA receptor MeSH Browser
- Pregnenolone MeSH
- pregnenolone sulfate MeSH Browser
- Receptors, N-Methyl-D-Aspartate MeSH
- Recombinant Proteins MeSH